Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

John Sutton

Thoracic Surgery (Cardiothoracic Vascular Surgery) Columbia, SC Medical Doctor

NPI 1265402762 CMS profile 101936

2750 Laurel St Ste 305, Columbia, SC 29204

Open in the dashboard

General payments

$11,414

107 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Sutton of Columbia, SC is reported in the CMS Open Payments database as having received $11,414 across 107 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,145 47
2024 General $1,474 30
2023 General $191 10
2022 General $331 5
2021 General $112 6
2020 General $61 3
2019 General $101 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Sutton
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to John Sutton were reported at $9,145. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year John Sutton Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $101 $886 $178–$3,167 $163
2020 $61 $341 $108–$1,605 $114
2021 $112 $453 $125–$1,886 $132
2022 $331 $695 $180–$2,566 $149
2023 $191 $745 $205–$2,662 $160
2024 $1,474 $799 $214–$2,967 $164
2025 $9,145 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $6,222 11 payments
  2. Medtronic, Inc. $1,511 27 payments
  3. CryoLife, Inc. $1,284 4 payments
  4. Abbott Laboratories $996 11 payments
  5. Atricure, Inc. $696 30 payments
  6. Maquet Cardiovascular U.S. Sales, L.L.C. $246 6 payments
  7. Edwards Lifesciences Corporation $186 3 payments
  8. Biotronik Inc. $75 4 payments
  9. Chiesi USA, Inc. $37 2 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29 2 payments
  11. Other $133 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $5,520 4 payments
  2. Travel and Lodging $3,074 15 payments
  3. Food and Beverage $2,821 88 payments
Products named General payments · program years 2019–2025
  1. DAVINCI XI $5,500 3 payments
  2. AMDS-Ascyrus Medical $1,284 4 payments
  3. EVERA MRI XT DR SURESCAN $1,003 9 payments
  4. AVEIR $950 9 payments
  5. Da Vinci Surgical System $722 8 payments
  6. ATRICLIP LAA EXCLUSION SYSTEM $622 24 payments
  7. SYNERGY ABLATION SYSTEM $424 15 payments
  8. COREVALVE EVOLUT R $210 5 payments
  9. MITRIS RESILIA Mitral Valve $152 1 payment
  10. ENDURANT IIS $117 5 payments
  11. Other $912 43 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

153

Median for Cardiac Surgery: 68

Drug cost

$7,724

Median for Cardiac Surgery: $445

Branded share of claims

15.7%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Jardiance Empagliflozin Brand 12 $6,918
Amiodarone Hcl Generic 17 $362
Atorvastatin Calcium Generic 31 $130
Clopidogrel Clopidogrel Bisulfate Brand 12 $112
Tramadol Hcl Generic 38 $80
Metoprolol Tartrate Generic 17 $62
Carvedilol Generic 11 $33
Spironolactone Generic 15 $26

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 67 billing codes

Paid by Medicare

$150,711

Medicare's payments for the services billed

Medicare patients

248

Average age 76

Services billed

442

98 women, 150 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 70%
Atrial fibrillation 52%
Arthritis 51%
Diabetes 44%
Heart failure 44%
Chronic kidney disease 38%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

107 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record